TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS

Abstract

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy. This study is conducted in adult transplant patients.

Key facts

NIH application ID

10576258

Project number

272201600015C-P00009-9999-1

Recipient

FRED HUTCHINSON CANCER CENTER

Principal Investigator

MICHAEL BOECKH

Activity code

N01

Funding institute

NIH

Fiscal year

2022

Award amount

$1,120,409

Award type

—

Project period

2016-07-01 → 2023-08-15